Kymera Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $11M | 193k | 56.60 |
| 2025-03-31 | $1.3M | 47k | 27.37 |
| 2024-12-31 | $1.5M | 37k | 40.23 |
| 2024-09-30 | $6.6M | 141k | 47.33 |
| 2024-06-30 | $1.3M | 45k | 29.85 |
| 2024-03-31 | $18M | 456k | 40.20 |
| 2023-12-31 | $13M | 512k | 25.46 |
| 2023-09-30 | $8.6M | 622k | 13.90 |
| 2023-06-30 | $15M | 656k | 22.99 |
| 2023-03-31 | $16M | 519k | 30.84 |
| 2022-12-31 | $14M | 552k | 24.96 |
| 2022-06-30 | $12M | 603k | 19.69 |
| 2022-03-31 | $6.9M | 164k | 42.31 |
| 2021-12-31 | $12M | 181k | 63.49 |
| 2021-03-31 | $2.3M | 59k | 38.86 |
| 2020-12-31 | $1.2M | 22k | 53.57 |